Paul Saladino· MD
comorbidities were present in 67% of the non survivor group so almost 70% of the non survivor group had a comorbidity and 40% of the survivor group had a comorbidity
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
comorbidities were present in 67% of the non survivor group so almost 70% of the non survivor group had a comorbidity and 40% of the survivor group had a comorbidity
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
you can see chronic lung disease again much higher in the non survivors
comorbidities were present in 67% of the non survivor group so almost 70% of the non survivor group had a comorbidity and 40% of the survivor group had a comorbidity